Search Results for: Regulation (EC) No 469/2009 3

Click the case name for better results:

Royalty Pharma Collection Trust (Judgment): ECJ 30 Apr 2020

Reference for a preliminary ruling – Intellectual and industrial property – Regulation (EC) No 469/2009 – Supplementary protection certificate for medicinal products – Conditions for obtaining – Article 3 (a) – Concept of ‘product protected by a basic patent in force ‘- Assessment criteria Citations: C-650/17, [2020] EUECJ C-650/17, ECLI:EU:C:2020:327, [2019] EUECJ C-650/17_O Links: Bailii, … Continue reading Royalty Pharma Collection Trust (Judgment): ECJ 30 Apr 2020

Eli Lilly And Company Ltd v Human Genome Sciences Inc: ECJ 12 Dec 2013

ECJ Medicinal products for human use – Supplementary protection certificate – Regulation (EC) No 469/2009 – Article 3 – Conditions for obtaining such a certificate – Concept of a ‘product protected by a basic patent in force’ – Criteria – Wording of the claims of the basic patent – Precision and specificity – Functional definition … Continue reading Eli Lilly And Company Ltd v Human Genome Sciences Inc: ECJ 12 Dec 2013

Neurim Pharmaceuticals v Comptroller-General of Patents: ECJ 3 May 2012

(Order) Medicinal products for human use – Supplementary protection certificate – Regulation (EEC) No 1768/92 – Article 3 – Conditions for obtaining supplementary protection certificates – First authorisation to place a product on the market in the Member State for which the application is made – Successive authorisations to place a product on the market … Continue reading Neurim Pharmaceuticals v Comptroller-General of Patents: ECJ 3 May 2012

ViiV Healthcare UK Ltd v Teva UK Ltd: ChD 23 Apr 2015

Application for a reference to the European Court of Justice in an action in which the Claimant (ViiV) seeks a declaration as to the proper interpretation of Article 3 of the Regulation in the context of a Supplementary Protection Certificate granted in 2005 in respect of ‘A combination comprising abacavir, optionally in the form of … Continue reading ViiV Healthcare UK Ltd v Teva UK Ltd: ChD 23 Apr 2015

Merck Canada Inc. (Order Of The Court): ECJ 13 Feb 2014

ECJ Preliminary ruling – Concept of national jurisdiction within the meaning of Article 267 TFEU – Necessario Arbitral Tribunal – Admissibility – Regulation (EC) No 469/2009 – Article 13 – Supplementary protection certificate for medicinal products – Validity of certificate – Maximum Exclusivity Period C-555/13, [2014] EUECJ C-555/13 Bailii European Intellectual Property Updated: 30 November … Continue reading Merck Canada Inc. (Order Of The Court): ECJ 13 Feb 2014

Georgetown University v Octrooicentrum Nederland: ECJ 12 Dec 2013

ECJ Medicinal products for human use – Supplementary protection certificate – Regulation (EC) No 469/2009 – Article 3 – Conditions for obtaining such a certificate – Whether it is possible to obtain a number of supplementary protection certificates on the basis of just one patent C-484/12, [2013] EUECJ C-484/12 Bailii Regulation (EC) No 469/2009 European … Continue reading Georgetown University v Octrooicentrum Nederland: ECJ 12 Dec 2013

Actavis Uk Ltd v Sanofi: ECJ 12 Dec 2013

ECJ Medicinal products for human use – Supplementary protection certificate – Regulation (EC) No 469/2009 – Article 3 – Conditions for obtaining such a certificate – Successive marketing of two medicinal products containing, wholly or partially, the same active ingredient – Combination of active ingredients, one of which has already been marketed in the form … Continue reading Actavis Uk Ltd v Sanofi: ECJ 12 Dec 2013

Actavis Group Ptc And Actavis UK v Boehringer Ingelheim Pharma GmbH and Co. KG: ECJ 12 Mar 2015

ECJ Judgment – Reference for a preliminary ruling – Medicinal products for human use – Regulation (EC) No 469/2009 – Article 3 – Supplementary protection certificate – Conditions for obtaining such a certificate – Medicinal products containing in whole or in part the same active ingredient – Medicinal products placed on the market in succession … Continue reading Actavis Group Ptc And Actavis UK v Boehringer Ingelheim Pharma GmbH and Co. KG: ECJ 12 Mar 2015

Seattle Genetics Inc v Osterreichisches Patentamt: ECJ 6 Oct 2015

ECJ Judgment – Reference for a preliminary ruling – Intellectual and industrial property – Proprietary medicinal products – Regulation (EC) No 469/2009 – Article 13(1) – Supplementary protection certificate – Duration – Concept of the ‘date of the first authorisation to place the product on the market in the European Union’ – Whether account is … Continue reading Seattle Genetics Inc v Osterreichisches Patentamt: ECJ 6 Oct 2015

Neurim Pharmaceuticals (1991) Ltd v Comptroller-General of Patents: ECJ 19 Jul 2012

Medicinal products for human use – Supplementary protection certificate – Regulation (EC) No 469/2009 – Article 3 – Conditions for obtaining a supplementary protection certificate – Medicinal product having obtained a valid marketing authorisation – First authorisation – Product successively authorised as a veterinary medicinal product and a human medicinal product Citations: [2012] EUECJ C-130/11, … Continue reading Neurim Pharmaceuticals (1991) Ltd v Comptroller-General of Patents: ECJ 19 Jul 2012

Pfizer Ireland Pharmaceuticals, Operations Support Group v Orifarm GmbH: ECJ 21 Jun 2018

(Judgment) Reference for a preliminary ruling – Intellectual and industrial property – Patent law – Acts of Accession to the European Union of 2003, 2005 and 2012 – Specific Mechanism – Whether applicable to parallel imports – Regulation (EC) No 469/2009 – Product protected by a supplementary protection certificate in a Member State and marketed … Continue reading Pfizer Ireland Pharmaceuticals, Operations Support Group v Orifarm GmbH: ECJ 21 Jun 2018

Teva UK and Others v Gilead Sciences Inc: ECJ 25 Apr 2018

ECJ Patent Law – Supplementary Protection Certificate for Medicinal Products – Opinion – Request for a preliminary ruling – Approximation of laws – Patent law – Supplementary protection certificate for medicinal products – Regulation (EC) No 469/2009 – Article 3(a) – Conditions for obtaining – Product protected by a basic patent in force – Criteria … Continue reading Teva UK and Others v Gilead Sciences Inc: ECJ 25 Apr 2018

F Hoffmann-La Roche AG v Accord Healthcare OU: ECJ 5 Oct 2016

ECJ (Judgment) Reference for a preliminary ruling – Industrial and commercial property – Patent – Supplementary protection certificate – Regulation (EC) No 469/2009 – Article 21(2) – Transitional provisions – Certificate granted in accordance with the national legislation of a Member State prior to its accession to the European Union – Interpretation of Article 21(2) … Continue reading F Hoffmann-La Roche AG v Accord Healthcare OU: ECJ 5 Oct 2016

Forsgren v Osterreichisches Patentamt: ECJ 15 Jan 2015

ECJ Judgment – Reference for a preliminary ruling – Medicinal products for human use – Supplementary protection certificate – Regulation (EC) No 469/2009 – ‘Active ingredient’ – Pneumococcal conjugate vaccine – Paediatric use – Carrier protein – Covalent binding) C. Toader, acting as P C-631/13, [2015] EUECJ C-631/13, ECLI:EU:C:2015:13 Bailii European Updated: 27 December 2021; … Continue reading Forsgren v Osterreichisches Patentamt: ECJ 15 Jan 2015